TapImmune Inc (NASDAQ:TPIV)

2.71
Delayed Data
As of Apr 26
 -0.07 / -2.52%
Today’s Change
2.58
Today|||52-Week Range
4.70
-30.87%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for TapImmune Inc have a median target of 5.50, with a high estimate of 5.50 and a low estimate of 5.50. The median estimate represents a +102.95% increase from the last price of 2.71.

Analyst Recommendations

The current consensus among 1 polled investment analysts is to Outperform stock in TapImmune Inc. This rating has held steady since April, when it was unchanged from a Outperform rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
--
Reporting Date
TBD

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
 
 
Growthannually -29.31%
 
 
 
 

Sales

Growthquarterly --
Growthannually --
Key to the earnings and sales forecast charts.